Central Serous Chorioretinopathy and Micropulse Laser Treatment: Evaluation of Morphological and Functional Recovery
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
View:
• Diagnosis of central serous chorioretinopathy (CSC) with no response to conservative therapy, consisted in Acetazolamide and Eplerenone after six months.
• Foveal serous retinal detachment for at least 6 months.
• Minimum age of 18 years old at the screening time
• Reading and comprehension skills of informed consent
Locations
Other Locations
Italy
Fondazione Policlinico Agostino Gemelli, IRCCS
RECRUITING
Roma
Contact Information
Primary
Maria Cristina Savastano, MD, PhD
mariacristinasavastano@policlinicogemelli.it
(+39)063015
Time Frame
Start Date: 2023-05-31
Estimated Completion Date: 2027-05-31
Participants
Target number of participants: 36
Related Therapeutic Areas
Sponsors
Leads: Fondazione Policlinico Universitario Agostino Gemelli IRCCS